Matthew Lee

Managing Director

London Mergers & Acquisitions Healthcare mlee@lincolninternational.com +44 20 7632 5253

It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.

Who We Are / Our People / Matthew Lee

Matthew provides mergers and acquisitions (M&A) advisory services and co-heads Lincoln’s European Healthcare Group. Matthew has nearly 20 years of M&A advisory experience, executing both sell-side and buy-side transactions for private equity clients, publicly traded companies and privately held and family-owned businesses. His experience spans both the UK and international markets.

Matthew specializes in advising companies across many sub-verticals of the human ‘healthcare services’ ecosystem but is also a leader in the animal health sector. Matthew delivers on clients’ ambitions by providing hands-on, independent advice while leveraging the global Lincoln healthcare network.

Prior to joining Lincoln, Matthew worked at KPMG as a senior member of its healthcare M&A team for eight years. Earlier in his career, he worked at Rothschild & Co in the healthcare team and Altium Capital, both M&A advisory firms in London. Matthew also brings direct experience in the private equity market, having worked for two years at Lloyds Development Capital, a middle market-focused UK investor.

Matthew earned a Bachelor of Science from the University of Bath and holds a Securities Institute Diploma.

Recent Transactions

Lincoln International advised Bluegem Capital Partners on its sale of The Private Clinic to The Quadrivio Group

Consumer

Lincoln International advised IVC Evidensia, a portfolio company of EQT Partners, on its sale of a group of veterinary practices to Perwyn

Healthcare

Lincoln International advised Millbrook Healthcare Group on the sale of Ross Care to Medequip, a subsidiary of Medux

Healthcare

Lincoln International advised Standard Investment on the sale of Dierenartsen Groep Nederland to VetPartners, a portfolio company of BC Partners

Consumer | Healthcare

H2 Equity Partners Optegra Mid Europa Partners 2023

Lincoln International advised H2 Equity Partners on the sale of Optegra to MidEuropa

Healthcare

Duomed Group G Square The Surgical Company French The Surgical Company 2022

Lincoln International advised Duomed, a portfolio company of G Square, on its acquisition of the French and Belgian distribution activities of The Surgical Company

Healthcare

All About Children Nurseries Partou Waterland 2022

Lincoln International has advised All About Children on its sale to Partou, a portfolio company of Waterland Private Equity

Healthcare

Lincoln International advised Perwyn on the acquisition of European Sperm Bank from Axcel

Healthcare

Showing 1 – 8 of 32

Perspectives featuring Matthew Lee

Outsourced Healthcare Logistics: Ripe for Private Equity Investment

Ample consolidation opportunity for private equity (PE) to capitalize on accelerating healthcare trends and consistent well-above GDP growth rates Favorable market fundamentals supporting the mid-and-long-term outlook for healthcare third-party… Read More

Event | Economic and Healthcare Spending

On 6 November 2021, the Lincoln International Healthcare team hosted a C-Suite focused evening at Dartmouth House in Mayfair, co-sponsored by CIL Consulting and Global Counsel, with guest speakers David… Read More

Animal Health Players Pursue Vertical Integration as a Path to Growth

Animal health businesses that have established a strong presence within their area of expertise, may be considering where the next best path to growth lies. While cross-border expansion and consolidation… Read More

Cross-Border Deals: The Right Prescription for Animal Health

As the humanization of pets continues and pet lifespans grow longer, investment opportunities in animal health abound. While most animal health companies will first look for growth within their own… Read More

Showing 1 – 4 of 12